RMD RESMED INC
2026Q1 · CUSIP 761152107 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
935
Δ holders QoQ
-12
Breadth percentile
Top 88%
Whale holders
292
Δ whales
+6
Inst. holding value
$21.5B
New positions
103
Closed positions
115
Price momentum (1Q)
-20.0%
Put / Call
15/12
Breadth history (34 quarters)
Past Lit Events & Aftermath 21 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q3 | Top 10% | +5.0% | -13.8% |
| 2025Q2 | Top 8% | -14.4% | -9.1% |
| 2025Q1 | Top 15% | +13.1% | -3.0% |
| 2024Q4 | Top 7% | +10.1% | +24.6% |
| 2024Q3 | Top 12% | -3.0% | +3.0% |
| 2024Q2 | Top 2% | +1.8% | +3.4% |
| 2024Q1 | Top 10% | +6.1% | +7.9% |
| 2023Q4 | Top 17% | +21.4% | +28.8% |
Options Sentiment
Put holders
15
QoQ: -3
Call holders
12
QoQ: -4
See methodology →
Fundamentals
PE (TTM)
18.7
EPS (TTM)
$10.37
EPS YoY
+16.5%
Revenue (TTM)
$5.5B
Revenue YoY
+10.3%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)